Anterior and Posterior Approaches of Suprascapular Nerve Block

NCT ID: NCT05442814

Last Updated: 2024-03-06

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 60 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2022-03-15
• Study Completion Date: 2023-03-15

Brief Summary

Suprascapular nerve is a mixed motor and sensory peripheral nerve arising from the superior trunk of brachial plexus.The suprascapular nerve runs through the posterior triangle of the neck, anterior of the trapezius muscle and dorsal of the omohyoid muscle, in direction of the scapula. Suprascapular nerve block is performed by anterior and posterior approach. Posterior approach of the suprascapular nerve block has been shown for many years to provide effective analgesia in the shoulder region for the chronic and acute pain. There are studies showing that suprascapular block with anterior approach provides effective analgesia in shoulder arthroscopy.

The aim of our study was to compare anterior and posterior approaches of suprascapular nerve block in terms of analgesic efficacy and patient safety.

Detailed Description

This study is a prospective randomized clinical trial will be conducted between March 2022 and March 2023.Participant will divide into two groups as participant who underwent suprascapular nerve block with the anterior approach and participant who underwent suprascapular nerve block with the posterior approach. Bupivacaine 5 ml %0.5 will be injected both group. Diaphragmatic thickness fraction will be evaluated with ultrasound left and right 7.-8. subcostal anterior axillary border with the participant with the semi-sitting position. Diaphragmatic thickness fraction will measure before the block and after 30 minutes the surgery. Participants will administered intravenous morphine patient controlled analgesia for 24 hours stay. The amount of opioid analgesics given in both groups will be determined (in mg). Postoperative 4th, 6th, 12th, 24th hour Visual Analogue Scale scores of the participants and opioid consumptions until that hours will be evaluated. An addition participant will be determined according to the surgery.

Conditions

Shoulder Pain; Postoperative Pain; Diaphragmatic Paralysis; Subomohyoid Suprascapular Nerve Block; Anterior Suprascapular Nerve Block; Suprascapular Nerve Block

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: SINGLE

Study Groups

Posterior suprascapular block

Suprascapular block performed by posterior approach

Group Type: ACTIVE_COMPARATOR

Posterior suprascapular block

Intervention Type: PROCEDURE

Diaphragmatic thickness fraction will be evaluated in the participant underwent suprascapular block performed by posterior approach

Anterior suprascapular block

Suprascapular block performed by anterior approach

Group Type: ACTIVE_COMPARATOR

Anterior suprascapular block

Intervention Type: PROCEDURE

Diaphragmatic thickness fraction will be evaluated in the participant underwent suprascapular block performed by anterior approach

Interventions

Posterior suprascapular block

Diaphragmatic thickness fraction will be evaluated in the participant underwent suprascapular block performed by posterior approach

Intervention Type: PROCEDURE

Anterior suprascapular block

Diaphragmatic thickness fraction will be evaluated in the participant underwent suprascapular block performed by anterior approach

Intervention Type: PROCEDURE

Eligibility Criteria

Inclusion Criteria

• Patient who accepts to study protocol
• Scheduled for shoulder surgery
• Between the ages of 18 and 80

Exclusion Criteria

• Patients with coagulopathy
• Patients with a history of local anesthetic drug allergy and toxicity
• Patients with advanced organ failure
• Patients with mental retardation
• Patients with infection present at the injection site
• Patients with diaphragm paralysis
• Pregnant patients

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 80 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Istanbul Medeniyet University

OTHER

Sponsor Role: lead

Responsible Party

Ebru Girgin Dinç, MD

Principal Investigator

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Ebru Girgin Dinç, MD

Role: PRINCIPAL_INVESTIGATOR

İstanbul Medeniyet University

Locations

Istanbul Medeniyet University

Istanbul, , Turkey (Türkiye)

Countries

Turkey (Türkiye)

Other Identifiers

EDinc

Identifier Type: -

Identifier Source: org_study_id